Mustang Bio (MBIO) Expected to Announce Earnings on Monday

Mustang Bio (NASDAQ:MBIO) will likely be issuing its quarterly earnings data before the market opens on Monday, March 10th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter.

Mustang Bio Price Performance

Shares of MBIO opened at $1.48 on Friday. Mustang Bio has a one year low of $1.46 and a one year high of $67.00. The company has a 50-day moving average of $5.05 and a two-hundred day moving average of $9.50. The stock has a market cap of $1.41 million, a price-to-earnings ratio of -0.02 and a beta of 1.82.

About Mustang Bio

Mustang Bio, Inc, a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.